Fazry S, Najm A, Mahdi I, Ang A, Lee L, Loh C
PeerJ. 2024; 12:e17894.
PMID: 39346049
PMC: 11439379.
DOI: 10.7717/peerj.17894.
Wu Y, Xie L, Liu Y, Xie L
Commun Biol. 2024; 7(1):1104.
PMID: 39251833
PMC: 11383949.
DOI: 10.1038/s42003-024-06797-z.
Al Khoury C, Tokajian S, Nemer N, Nemer G, Rahy K, Thoumi S
Metabolites. 2024; 14(4).
PMID: 38668360
PMC: 11051850.
DOI: 10.3390/metabo14040232.
Chirasani V, Wang J, Sha C, Raup-Konsavage W, Vrana K, Dokholyan N
Curr Res Chem Biol. 2023; 2.
PMID: 38125869
PMC: 10732549.
DOI: 10.1016/j.crchbi.2022.100035.
Law D, Najm A, Chong J, Kng J, Amran M, Ching H
PeerJ. 2023; 11:e15651.
PMID: 37483971
PMC: 10362845.
DOI: 10.7717/peerj.15651.
Comparing methods for drug-gene interaction prediction on the biomedical literature knowledge graph: performance versus explainability.
Aisopos F, Paliouras G
BMC Bioinformatics. 2023; 24(1):272.
PMID: 37391722
PMC: 10311852.
DOI: 10.1186/s12859-023-05373-2.
Computer-aided drug design for the pain-like protease (PL) inhibitors against SARS-CoV-2.
Gao H, Dai R, Su R
Biomed Pharmacother. 2023; 159:114247.
PMID: 36689835
PMC: 9841087.
DOI: 10.1016/j.biopha.2023.114247.
End-to-end sequence-structure-function meta-learning predicts genome-wide chemical-protein interactions for dark proteins.
Cai T, Xie L, Zhang S, Chen M, He D, Badkul A
PLoS Comput Biol. 2023; 19(1):e1010851.
PMID: 36652496
PMC: 9886305.
DOI: 10.1371/journal.pcbi.1010851.
The Pharmacorank Search Tool for the Retrieval of Prioritized Protein Drug Targets and Drug Repositioning Candidates According to Selected Diseases.
Gnilopyat S, DePietro P, Parry T, McLaughlin W
Biomolecules. 2022; 12(11).
PMID: 36358909
PMC: 9687941.
DOI: 10.3390/biom12111559.
Small molecule modulation of microbiota: a systems pharmacology perspective.
Liu Q, Lee B, Xie L
BMC Bioinformatics. 2022; 23(Suppl 3):403.
PMID: 36175827
PMC: 9523894.
DOI: 10.1186/s12859-022-04941-2.
Reinforcement learning for systems pharmacology-oriented and personalized drug design.
Tan R, Liu Y, Xie L
Expert Opin Drug Discov. 2022; 17(8):849-863.
PMID: 35510835
PMC: 9824901.
DOI: 10.1080/17460441.2022.2072288.
Collateral responses to classical cytotoxic chemotherapies are heterogeneous and sensitivities are sparse.
Dalin S, Grauman-Boss B, Lauffenburger D, Hemann M
Sci Rep. 2022; 12(1):5453.
PMID: 35361803
PMC: 8971507.
DOI: 10.1038/s41598-022-09319-1.
DeepREAL: a deep learning powered multi-scale modeling framework for predicting out-of-distribution ligand-induced GPCR activity.
Cai T, Abbu K, Liu Y, Xie L
Bioinformatics. 2022; 38(9):2561-2570.
PMID: 35274689
PMC: 9048666.
DOI: 10.1093/bioinformatics/btac154.
A Birds-Eye (Re)View of Acid-Suppression Drugs, COVID-19, and the Highly Variable Literature.
Mura C, Preissner S, Preissner R, Bourne P
Front Pharmacol. 2021; 12:700703.
PMID: 34456726
PMC: 8385362.
DOI: 10.3389/fphar.2021.700703.
(Burm. f.) Wall. ex Nees: An Updated Review of Phytochemistry, Antimicrobial Pharmacology, and Clinical Safety and Efficacy.
Hossain S, Urbi Z, Karuniawati H, Mohiuddin R, Moh Qrimida A, Allzrag A
Life (Basel). 2021; 11(4).
PMID: 33923529
PMC: 8072717.
DOI: 10.3390/life11040348.
Involvement of Machine Learning Tools in Healthcare Decision Making.
Jayatilake S, Ganegoda G
J Healthc Eng. 2021; 2021:6679512.
PMID: 33575021
PMC: 7857908.
DOI: 10.1155/2021/6679512.
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.
Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N
Bioorg Chem. 2020; 106:104490.
PMID: 33261845
PMC: 7676368.
DOI: 10.1016/j.bioorg.2020.104490.
Sex-Biased Molecular Signature for Overall Survival of Liver Cancer Patients.
Kim S, Song H, Lee S, Kim S, Woo H, Yang J
Biomol Ther (Seoul). 2020; 28(6):491-502.
PMID: 33077700
PMC: 7585639.
DOI: 10.4062/biomolther.2020.157.
COVID-19 pandemic is not the time of trial and error.
Mohamed K, Rezaei N
Am J Emerg Med. 2020; 46:774-775.
PMID: 32988694
PMC: 7489261.
DOI: 10.1016/j.ajem.2020.09.020.
Repurposing cefuroxime for treatment of COVID-19: a scoping review of studies.
Durojaiye A, Clarke J, Stamatiades G, Wang C
J Biomol Struct Dyn. 2020; 39(12):4547-4554.
PMID: 32538276
PMC: 7298880.
DOI: 10.1080/07391102.2020.1777904.